Companies Cryptocurrencies
Keros Therapeutics Inc
Keros Therapeutics Inc
Exchange: NasdaqGS
IPO Date: 08/04/2020
CEO: Dr. Jasbir Seehra
Biotechnology Healthcare 🔗
  • KROS
  • 28.5
  • 684994624
    market cap
  • -0.3600006
If you bought

shares of Keros Therapeutics Inc (KROS) on
You would have made
Old Price $12 Current Price $12

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. Its protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes (MDS) and myelofibrosis. Its small molecule product candidate, KER-047, is being developed for the treatment of anemia resulting from elevated levels of hepcidin, the key regulator of iron absorption and recycling, as well as for the treatment of fibrodysplasia ossificans progressive. KER-047 is in a Phase I clinical trial. Its KER-012 is being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension.

Address: 99 Hayden Ave Ste 120 (Bld E Lexington MASSACHUSETTS 02421

Stay updated.